Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Regeneron Pharmaceuticals, Inc. Transaction History

Mitsubishi Ufj Kokusai Asset Management Co., Ltd.

  • $122 Billion
  • Q2 2025

A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 209,063 shares of REGN stock, worth $116 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
209,063
Previous 198,850 5.14%
Holding current value
$116 Million
Previous $126 Million 12.97%
% of portfolio
0.09%
Previous 0.12%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 07, 2025
BUY
$483.07 - $625.6 $4.93 Million - $6.39 Million
10,213 Added 5.14%
209,063 $110 Million
Q1 2025

May 12, 2025
BUY
$634.14 - $744.83 $13.9 Million - $16.3 Million
21,842 Added 12.34%
198,850 $126 Million
Q4 2024

Feb 12, 2025
BUY
$701.85 - $1046.91 $8.95 Million - $13.4 Million
12,757 Added 7.77%
177,008 $126 Million
Q3 2024

Nov 07, 2024
BUY
$1024.09 - $1201.76 $15.4 Million - $18.1 Million
15,081 Added 10.11%
164,251 $173 Million
Q2 2024

Aug 12, 2024
BUY
$883.2 - $1071.19 $14.4 Million - $17.5 Million
16,306 Added 12.27%
149,170 $157 Million
Q1 2024

May 09, 2024
BUY
$902.69 - $993.35 $19.4 Million - $21.4 Million
21,528 Added 19.34%
132,864 $128 Million
Q4 2023

Feb 08, 2024
BUY
$775.18 - $881.7 $4.34 Million - $4.94 Million
5,603 Added 5.3%
111,336 $97.8 Million
Q3 2023

Nov 07, 2023
BUY
$692.45 - $844.37 $5.76 Million - $7.03 Million
8,320 Added 8.54%
105,733 $87 Million
Q2 2023

Aug 09, 2023
BUY
$700.03 - $830.35 $4.47 Million - $5.3 Million
6,385 Added 7.01%
97,413 $70 Million
Q1 2023

May 08, 2023
BUY
$680.49 - $826.97 $5.99 Million - $7.28 Million
8,805 Added 10.71%
91,028 $74.8 Million
Q4 2022

Feb 07, 2023
BUY
$705.89 - $766.39 $5.59 Million - $6.07 Million
7,914 Added 10.65%
82,223 $59.3 Million
Q3 2022

Nov 01, 2022
BUY
$573.97 - $724.32 $3.92 Million - $4.94 Million
6,822 Added 10.11%
74,309 $51.2 Million
Q2 2022

Aug 04, 2022
BUY
$548.35 - $738.84 $2.88 Million - $3.88 Million
5,248 Added 8.43%
67,487 $39.9 Million
Q1 2022

May 09, 2022
BUY
$595.12 - $698.43 $3.32 Million - $3.9 Million
5,583 Added 9.85%
62,239 $43.5 Million
Q4 2021

Feb 07, 2022
BUY
$543.48 - $670.97 $4.83 Million - $5.96 Million
8,889 Added 18.61%
56,656 $35.5 Million
Q3 2021

Nov 04, 2021
BUY
$574.03 - $680.96 $2.61 Million - $3.09 Million
4,541 Added 10.51%
47,767 $28.9 Million
Q2 2021

Aug 06, 2021
BUY
$472.8 - $558.54 $2.62 Million - $3.09 Million
5,535 Added 14.69%
43,226 $24.1 Million
Q1 2021

May 06, 2021
BUY
$446.73 - $548.2 $2.11 Million - $2.58 Million
4,713 Added 14.29%
37,691 $17.8 Million
Q4 2020

Feb 09, 2021
BUY
$478.3 - $607.98 $1.1 Million - $1.4 Million
2,303 Added 7.51%
32,978 $15.9 Million
Q3 2020

Nov 10, 2020
BUY
$544.75 - $658.21 $2.43 Million - $2.94 Million
4,462 Added 17.02%
30,675 $17.2 Million
Q2 2020

Aug 06, 2020
BUY
$493.32 - $643.92 $4.46 Million - $5.83 Million
9,050 Added 52.73%
26,213 $16.3 Million
Q1 2020

May 11, 2020
BUY
$336.18 - $494.43 $8,740 - $12,855
26 Added 0.15%
17,163 $8.38 Million
Q4 2019

Feb 05, 2020
BUY
$274.13 - $376.51 $500,287 - $687,130
1,825 Added 11.92%
17,137 $6.33 Million
Q3 2019

Nov 12, 2019
BUY
$273.46 - $318.39 $226,971 - $264,263
830 Added 5.73%
15,312 $4.25 Million
Q2 2019

Aug 08, 2019
BUY
$299.6 - $414.82 $1.07 Million - $1.47 Million
3,555 Added 32.53%
14,482 $4.53 Million
Q1 2019

Apr 26, 2019
BUY
$372.08 - $439.57 $229,201 - $270,775
616 Added 5.97%
10,927 $4.49 Million
Q4 2018

Feb 08, 2019
SELL
$335.82 - $403.04 $667,274 - $800,840
-1,987 Reduced 16.16%
10,311 $3.84 Million
Q3 2018

Nov 13, 2018
SELL
$351.14 - $408.51 $9,480 - $11,029
-27 Reduced 0.22%
12,298 $4.97 Million
Q2 2018

Aug 09, 2018
BUY
$284.6 - $344.99 $43,543 - $52,783
153 Added 1.26%
12,325 $4.25 Million
Q1 2018

May 02, 2018
SELL
$315.82 - $393.78 $665,116 - $829,300
-2,106 Reduced 14.75%
12,172 $4.19 Million
Q4 2017

Feb 06, 2018
BUY
$358.63 - $469.95 $161,383 - $211,477
450 Added 3.25%
14,278 $5.62 Million
Q3 2017

Nov 01, 2017
BUY
$431.38 - $504.0 $5.97 Million - $6.97 Million
13,828
13,828 $6.18 Million

Others Institutions Holding REGN

# of Institutions
1,398
Shares Held
85.3M
Call Options Held
1.39M
Put Options Held
1.42M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $59.7B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Portfolio

Follow Mitsubishi Ufj Kokusai Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email